Cannabinoid ‘model’ psychosis, dopamine–cannabinoid interactions and implications for schizophrenia

This publication has 63 references indexed in Scilit:

• SHORT COMMUNICATION Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids
  European Journal of Neuroscience, 2002
• ?1-adrenergic, D1, and D2 receptors interactions in the prefrontal cortex: Implications for the modality of action of different types of neuroleptics
  Synapse, 1998
• Increase in meso‐prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids
  European Journal of Neuroscience, 1998
• Measurement of dissociative states with the Clinician‐Administered Dissociative States Scale (CADSS)
  Journal of Traumatic Stress, 1998
• Roles of dopamine D1 receptors inΔ9-tetrahydrocannabinol-induced expression of Fos protein in the rat brain
  Brain Research, 1996
• Ventral tegmental microinjection of Δ9-tetrahydrocannabinol enhances ventral tegmental somatodendritic dopamine levels but not forebrain dopamine levels: evidence for local neural action by marijuana's psychoactive ingredient
  Brain Research, 1993
• Circuitry of Primate Prefrontal Cortex and Regulation of Behavior by Representational Memory
  Published by American Geophysical Union (AGU) ,1987
• Effects of Δ9-tetrahydrocannabinol on neurotransmitter accumulation and release mechanisms in rat forebrain synaptosomes
  Life Sciences, 1976
• Effect of an extract of cannabis and of some cannabinols on catecholamine metabolism in rat brain and heart
  Inflammation Research, 1970
• A Clinical and Metabolic Study of Acute Intoxication with Cannabis Sativa and its Role in the Model Psychoses
  Journal of Mental Science, 1958